Psychoneuroendocrinology
Volume 32, Issue 7 , Pages 834-842 , August 2007

The acceleration of amygdala kindling epileptogenesis by chronic low-dose corticosterone involves both mineralocorticoid and glucocorticoid receptors

  • Gaurav Kumar

      Affiliations

    • Department of Medicine, Royal Melbourne Hospital, University of Melbourne, Melbourne, Vic, Australia
    • Co-first authors.
    • ,
  • Abbie Couper

      Affiliations

    • Department of Medicine, Royal Melbourne Hospital, University of Melbourne, Melbourne, Vic, Australia
    • Co-first authors.
    • ,
  • Terence J. O’Brien

      Affiliations

    • Department of Medicine, Royal Melbourne Hospital, University of Melbourne, Melbourne, Vic, Australia
    • Department of Neurology, Royal Melbourne Hospital, University of Melbourne, Melbourne, Vic, Australia
    • ,
  • Michael R. Salzberg

      Affiliations

    • Department of Psychiatry, St. Vincent's Hospital, University of Melbourne, Melbourne, Vic, Australia
    • ,
  • Nigel C. Jones

      Affiliations

    • Department of Medicine, Royal Melbourne Hospital, University of Melbourne, Melbourne, Vic, Australia
    • Corresponding Author InformationCorresponding author. Tel.: +61383443273; fax: +61393471863.
    • ,
  • Sandra M. Rees

      Affiliations

    • Department of Anatomy and Cell Biology, University of Melbourne, Melbourne, Vic, Australia
    • ,
  • Margaret J. Morris

      Affiliations

    • Department of Physiology and Pharmacology, University of New South Wales, Sydney, NSW, Australia

Received 23 January 2007 ,Revised 24 April 2007 ,Accepted 24 May 2007.

References 

  1. Baram TZ, Hatalski CG. Neuropeptide-mediated excitability: a key triggering mechanism for seizure generation in the developing brain. Trends Neurosci. 1998;21:471–476
  2. Breuner CW, Orchinik M. Seasonal regulation of membrane and intracellular corticosteroid receptors in the house sparrow brain. J. Neuroendocrinol. 2001;13:412–420
  3. Cottrell GA, Nyakas C, de Kloet ER, Bohus B. Hippocampal kindling: corticosterone modulation of induced seizures. Brain Res. 1984;309:377–381
  4. DeBattista C, Belanoff J. The use of mifepristone in the treatment of neuropsychiatric disorders. Trends Endocrinol. Metab. 2006;17:117–121
  5. de Kloet ER, Vreugdenhil E, Oitzl MS, Joels M. Brain corticosteroid receptor balance in health and disease. Endocr. Rev. 1998;19:269–301
  6. Devinsky O. Diagnosis and treatment of temporal lobe epilepsy. Rev. Neurol. Dis. 2004;1:2–9
  7. Devinsky O, Barr WB, Vickrey BG, Berg AT, Bazil CW, Pacia SV, et al. Changes in depression and anxiety after resective surgery for epilepsy. Neurology. 2005;65:1744–1749
  8. Dominian J, Serafetinides EA, Dewhurst M. A follow-up study of late-onset epilepsy. II. Psychiatric and social findings. Brit. Med. J. 1963;5328:431–435
  9. Edwards HE, Burnham WM, Mendonca A, Bowlby DA, MacLusky NJ. Steroid hormones affect limbic afterdischarge thresholds and kindling rates in adult female rats. Brain Res. 1999;838:136–150
  10. Edwards HE, Vimal S, Burnham WM. The effects of ACTH and adrenocorticosteroids on seizure susceptibility in 15-day-old male rats. Exp. Neurol. 2002;175:182–190
  11. Engel JJ, Williamson PD, Wieser H-G. Mesial temporal lobe epilepsy. In:  Engel JJ,  Pedley TA editor. Epilepsy. A Comprehensive Textbook. PA: Lippincott-Raven Philadelphia; 1997;p. 2417–2426
  12. Fernandez MD, Carter GD, Palmer TN. The interaction of canrenone with oestrogen and progesterone receptors in human uterine cytosol. Brit. J. Clin. Pharmacol. 1983;15:95–101
  13. Fujikawa T, Soya H, Fukuoka H, Alam KS, Yoshizato H, McEwen BS, et al. A biphasic regulation of receptor mRNA expressions for growth hormone, glucocorticoid and mineralocorticoid in the rat dentate gyrus during acute stress. Brain Res. 2000;874:186–193
  14. Gould E, Woolley CS, McEwen BS. Short-term glucocorticoid manipulations affect neuronal morphology and survival in the adult dentate gyrus. Neuroscience. 1990;37:367–375
  15. Gould E, Tanapat P, Rydel T, Hastings N. Regulation of hippocampal neurogenesis in adulthood. Biol. Psychiatry. 2000;48:715–720
  16. Grabowska-Grzyb A, Jedrzejczak J, Naganska E, Fiszer U. Risk factors for depression in patients with epilepsy. Epilepsy Behav. 2006;8:411–417
  17. Harden CL. The co-morbidity of depression and epilepsy: epidemiology, etiology, and treatment. Neurology. 2002;59:S48–S55
  18. Herman JP, Cullinan WE. Neurocircuitry of stress: central control of the hypothalamo-pituitary-adrenocortical axis. Trends Neurosci. 1997;20:78–84
  19. Herman JP, Spencer R. Regulation of hippocampal glucocorticoid receptor gene transcription and protein expression in vivo. J. Neurosci. 1998;18:7462–7473
  20. Herman JP, Figueiredo H, Mueller NK, Ulrich-Lai Y, Ostrander MM, Choi DC, et al. Central mechanisms of stress integration: hierarchical circuitry controlling hypothalamo-pituitary-adrenocortical responsiveness. Front. Neuroendocrinol. 2003;24:151–180
  21. Hesdorffer DC, Hauser WA, Annegers JF, Cascino G. Major depression is a risk factor for seizures in older adults. Ann. Neurol. 2000;47:246–249
  22. Jezova D, Jurankova E, Mosnarova A, Kriska M, Skultetyova I. Neuroendocrine response during stress with relation to gender differences. Acta Neurobiol. Exp. (Wars). 1996;56:779–785
  23. Jobe PC. Common pathogenic mechanisms between depression and epilepsy: an experimental perspective. Epilepsy Behav. 2003;4(Suppl 3):S14–S24
  24. Joels M. Steroid hormones and excitability in the mammalian brain. Front. Neuroendocrinology. 1997;18:2–48
  25. Joels M, de Kloet ER. Mineralocorticoid and glucocorticoid receptors in the brain. Implications for ion permeability and transmitter systems. Prog. Neurobiol. 1994;43:1–36
  26. Kanner AM, Balabanov A. Depression and epilepsy: how closely related are they?. Neurology. 2002;58:S27–S39
  27. Karst H, Bosma A, Hendriksen E, Kamphuis W, de Kloet ER, Joels M. Effect of adrenalectomy in kindled rats. Neuroendocrinology. 1997;66:348–359
  28. Karst H, de Kloet ER, Joels M. Episodic corticosterone treatment accelerates kindling epileptogenesis and triggers long-term changes in hippocampal CA1 cells, in the fully kindled state. Eur. J. Neurosci. 1999;11:889–898
  29. Karst H, Berger S, Turiault M, Tronche F, Schutz G, Joels M. Mineralocorticoid receptors are indispensable for nongenomic modulation of hippocampal glutamate transmission by corticosterone. Proc. Natl. Acad. Sci. USA. 2005;102:19204–19207
  30. Kling MA, Smith MA, Glowa JR, Pluznik D, Demas J, DeBellis MD, et al. Facilitation of cocaine kindling by glucocorticoids in rats. Brain Res. 1993;629:163–166
  31. Koenig HN, Olive MF. The glucocorticoid receptor antagonist mifepristone reduces ethanol intake in rats under limited access conditions. Psychoneuroendocrinology. 2004;29:999–1003
  32. Krugers HJ, Knollema S, Kemper RH, Ter Horst GJ, Korf J. Down-regulation of the hypothalamo-pituitary-adrenal axis reduces brain damage and number of seizures following hypoxia/ischaemia in rats. Brain Res. 1995;690:41–47
  33. Lai MC, Holmes GL, Lee KH, Yang SN, Wang CA, Wu CL, et al. Effect of neonatal isolation on outcome following neonatal seizures in rats--the role of corticosterone. Epilepsy Res. 2006;68:123–136
  34. Lambert MV, Robertson MM. Depression in epilepsy: etiology, phenomenology, and treatment. Epilepsia. 1999;40(Suppl 10):S21–S47
  35. Makino S, Smith MA, Gold PW. Increased expression of corticotropin-releasing hormone and vasopressin messenger ribonucleic acid (mRNA) in the hypothalamic paraventricular nucleus during repeated stress: association with reduction in glucocorticoid receptor mRNA levels. Endocrinology. 1995;136:3299–3309
  36. McCullers DL, Sullivan PG, Scheff SW, Herman JP. Mifepristone protects CA1 hippocampal neurons following traumatic brain injury in rat. Neuroscience. 2002;109:219–230
  37. McEwen BS. Stress and hippocampal plasticity. Annu. Rev. Neurosci. 1999;22:105–122
  38. McEwen BS, Magarinos AM. Stress and hippocampal plasticity: implications for the pathophysiology of affective disorders. Hum. Psychopharmacol. 2001;16:S7–S19
  39. McEwen BS, Chattarji S. Molecular mechanisms of neuroplasticity and pharmacological implications: the example of tianeptine. Eur. Neuropsychopharmacol. 2004;14(Suppl 5):S497–S502
  40. Mejias-Aponte CA, Jimenez-Rivera CA, Segarra AC. Sex differences in models of temporal lobe epilepsy: role of testosterone. Brain Res. 2002;944:210–218
  41. Pariante CM. Glucocorticoid receptor function in vitro in patients with major depression. Stress. 2004;7:209–219
  42. Parker G, Hadzi-Pavlovic D. Is the female preponderance in major depression secondary to a gender difference in specific anxiety disorders?. Psychol. Med. 2004;34:461–470
  43. Pavlides C, Nivon LG, McEwen BS. Effects of chronic stress on hippocampal long-term potentiation. Hippocampus. 2002;12:245–257
  44. Paxinos G, Watson C. The Rat Brain in Stereotactic Coordinates. fifth ed. Elsevier Academic Press; 2005;
  45. Racine RJ. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr. Clin. Neurophysiol. 1972;32:281–294
  46. Reagan LP, McEwen BS. Controversies surrounding glucocorticoid-mediated cell death in the hippocampus. J. Chem. Neuroanat. 1997;13:149–167
  47. Roberts AJ, Keith LD. Mineralocorticoid receptors mediate the enhancing effects of corticosterone on convulsion susceptibility in mice. J. Pharmacol. Exp. Ther. 1994;270:505–511
  48. Roberts AJ, Keith LD. Sensitivity of the circadian rhythm of kainic acid-induced convulsion susceptibility to manipulations of corticosterone levels and mineralocorticoid receptor binding. Neuropharmacology. 1994;33:1087–1093
  49. Sanchez MM, Young LJ, Plotsky PM, Insel TR. Distribution of corticosteroid receptors in the rhesus brain: relative absence of glucocorticoid receptors in the hippocampal formation. J. Neurosci. 2000;20:4657–4668
  50. Sapolsky RM. Stress, the Aging Brain, and the Mechanisms of Neuron Death. Cambridge, Mass: MIT Press; 1992;
  51. Sapolsky RM. Stress, glucocorticoids, and damage to the nervous system: the current state of confusion. Stress. 1996;1:1–19
  52. Schwarzer C, Williamson JM, Lothman EW, Vezzani A, Sperk G. Somatostatin, neuropeptide Y, neurokinin B and cholecystokinin immunoreactivity in two chronic models of temporal lobe epilepsy. Neuroscience. 1995;69:831–845
  53. Semler DE, Chengelis CP, Radzialowski FM. The effects of chronic ingestion of spironolactone on serum thyrotropin and thyroid hormones in the male rat. Toxicol. Appl. Pharmacol. 1989;98:263–268
  54. Sutula T, Ockuly J. Kindling, spontaneous seizures, and the consequences of epilepsy: more than a model. In:  Pitkanen A,  Schwatzkroin P,  Moshe S editor. Models of Seizures and Epilepsy. Amsterdam: Elsevier; 2005;p. 395–406
  55. Taher TR, Salzberg M, Morris MJ, Rees S, O’Brien TJ. Chronic low-dose corticosterone supplementation enhances acquired epileptogenesis in the rat amygdala kindling model of TLE. Neuropsychopharmacology. 2005;30:1610–1616
  56. Takahashi T, Kimoto T, Tanabe N, Hattori TA, Yasumatsu N, Kawato S. Corticosterone acutely prolonged N-methyl-d-aspartate receptor-mediated Ca2+ elevation in cultured rat hippocampal neurons. J. Neurochem. 2002;83:1441–1451
  57. Talmi M, Carlier E, Bengelloun W, Soumireu-Mourat B. Synergistic action of corticosterone on kainic acid-induced electrophysiological alterations in the hippocampus. Brain Res. 1995;704:97–102
  58. van Praag HM. Crossroads of corticotropin releasing hormone, corticosteroids and monoamines. About a biological interface between stress and depression. Neurotox. Res. 2002;4:531–555
  59. van Praag HM. Can stress cause depression?. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2004;28:891–907
  60. van Riel E, Meijer OC, Steenbergen PJ, Joels M. Chronic unpredictable stress causes attenuation of serotonin responses in cornu ammonis 1 pyramidal neurons. Neuroscience. 2003;120:649–658
  61. Weiss G, Lucero K, Fernandez M, Karnaze D, Castillo N. The effect of adrenalectomy on the circadian variation in the rate of kindled seizure development. Brain Res. 1993;612:354–356
  62. Weiss GK, Castillo N, Fernandez M. Amygdala kindling rate is altered in rats with a deficit in the responsiveness of the hypothalamo-pituitary-adrenal axis. Neurosci. Lett. 1993;157:91–94
  63. Woolley CS, Gould E, McEwen BS. Exposure to excess glucocorticoids alters dendritic morphology of adult hippocampal pyramidal neurons. Brain Res. 1990;531:225–231

PII: S0306-4530(07)00122-9

doi: 10.1016/j.psyneuen.2007.05.011

Psychoneuroendocrinology
Volume 32, Issue 7 , Pages 834-842 , August 2007

Article Tools

* Image Usage & Resolution